Toremifene Decreases Vertebral Fractures in Men Younger Than 80 Years Receiving Androgen Deprivation Therapy for Prostate Cancer

PURPOSE: Androgen deprivation therapy (ADT) is associated with increased fracture risk. In a recent Phase III trial, toremifene significantly decreased vertebral fractures in men receiving ADT. Similar to other selective estrogen receptor modulators, toremifene was associated with an increase in ven...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Smith, Matthew R., Malkowicz, S. Bruce, Brawer, Michael K., Hancock, Michael L., Morton, Ronald A., Steiner, Mitchell S.
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3671875/
https://ncbi.nlm.nih.gov/pubmed/22014807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2011.07.090
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares